Role of MRI, Ultrasound, and Computed Tomography in the Management of Prostate Cancer

Nancy Mohsen
DOI: https://doi.org/10.1016/j.cpet.2022.07.002
Abstract:Computed tomography (CT), MRI, and Ultrasound play an evolving role in prostate cancer management. Multi-parametric MRI has high sensitivity and negative predictive value in prostate cancer diagnosis, leading to increased utilization as part of an active surveillance paradigm in low-to-intermediate-risk patients, and local tumor staging in high-grade cancers. CT is modestly sensitive in staging high-grade tumors to evaluate for nodal, liver, lung, and bone metastasis, and is preferred for assessing treatment related complications. Until recently, ultrasound has been limited to a guidance modality for biopsy and treatment; however, advances in micro-ultrasound technology aim to expand its role diagnosing and managing prostate cancer.
What problem does this paper attempt to address?